Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 140
Filtrer
1.
Neurotoxicology ; 94: 135-146, 2023 01.
Article de Anglais | MEDLINE | ID: mdl-36402195

RÉSUMÉ

BACKGROUND: Prenatal lead exposure is known to have neurotoxic effects on the developing fetus, while some viral infections may have a tropism for the central nervous system. Our objective was to study whether the effects of prenatal lead exposure on infant development and behaviors at 18 months of age are modified by the occurrence of a maternal infection to Zika virus (ZIKV) during pregnancy. METHODS: During the ZIKV epidemic in Guadeloupe in 2016 a cohort of pregnant women was set up. Blood samples (pregnancy, childbirth and cord) (n = 297) enabled us to measure blood lead levels aimed to determine prenatal lead exposure and the likelihood of maternal infection during pregnancy (ZIKV status + vs -). The 18 months "Ages and Stages Questionnaire" (ASQ) was used to generate scores for global development, fine and gross motor skills, communication, problem solving, and personal-social skills. The questions from a longitudinal cohort study conducted in Canada (Québec) were used to generate hyperactivity, opposition, inattention and physical aggression scores. Associations were tested by multivariate linear regressions. RESULTS: Prenatal lead exposure was associated with delays in neurodevelopment at 18 months, reflected by lower scores in ASQ totals, and in the fine motor and problem-solving domains. Some of these associations appeared to be sex-specific, observed almost exclusively in boys (ASQ total, fine motor and personal-social scores). Prenatal lead exposure was not associated with behavioral scores. ZIKV infection during pregnancy was associated with a lower fine motor ASQ score, and higher scores for hyperactivity, opposition and physical aggression. Significant interaction between prenatal lead exposure and ZIKV status was observed with a lower personal-social score in ZIKV (-) only, and for hyperactivity and inattention scores, though some of these interactions (ASQ personal-social score, inattention score) were no longer significant when children with microcephaly were excluded from the analyses. DISCUSSION/CONCLUSION: Our study confirms previous findings of associations between prenatal exposure to lead at low levels and adverse neurodevelopmental outcomes during infancy and the particular vulnerability of boys. It suggests associations between ZIKV infection during pregnancy and adverse effects on a number of neurodevelopmental functions (fine motor function) and behaviors (opposition, hyperactivity), that need to be confirmed at later age. There is no strong evidence of interaction between ZIKV infection and lead exposure but both prenatal risk factors may affect fine motor function.


Sujet(s)
Infection par le virus Zika , Virus Zika , Mâle , Enfant , Humains , Nourrisson , Grossesse , Femelle , Infection par le virus Zika/complications , Infection par le virus Zika/épidémiologie , Études longitudinales , Plomb/effets indésirables , Guadeloupe
2.
Infect Dis Now ; 52(4): 193-201, 2022 Jun.
Article de Anglais | MEDLINE | ID: mdl-35483634

RÉSUMÉ

Given the number of people leaving the war zone in Ukraine and arriving in France, the French high council for public health (HCSP) has drawn up a number of recommendations. The experts have taken into account the vulnerability of migrant populations, which is exacerbated by (a) promiscuity that increases the risk of exposure to infectious agents; (b) the psychological consequences of conflict, family separation and exile; (c) prevalence in Ukraine of communicable diseases such as (possibly multi-resistant) tuberculosis, HIV and HCV; (d) low vaccination coverage (risk of circulation of poliovirus) and (e) the risk of spreading infectious diseases (Covid-19, measles…). Consequently, experts recommend that priority be given to: (i) Initial (immediate) reception, which will help to provide emergency care and to assess immediate needs (psychological disorders, risk of medication breakdown and risk of infection); (ii) Other priority measures (vaccination catch-up, including vaccination against SARS-CoV-2 and mandatory vaccination for children's entry into school, screening for post-traumatic stress disorder and tuberculosis) must be implemented as soon as feasible. At this stage, it is imperative: To ensure coordination and access to information throughout the country, by providing medico-social support (opening of social rights and access to care); To digitize medical data for the purposes of traceability; To use professional interpreting and/or health facilitators, or else, if necessary, digital translation tools. (iii) Finally, experts stress the need for vigilance in terms of management, conservation of social rights and continuity of care after the initial period, and organization of a "health rendezvous" within four months of a migrant's entering the country.


Sujet(s)
COVID-19 , Population de passage et migrants , COVID-19/épidémiologie , Enfant , Humains , Santé publique , SARS-CoV-2 , Ukraine/épidémiologie
5.
Eur J Clin Microbiol Infect Dis ; 40(12): 2605-2616, 2021 Dec.
Article de Anglais | MEDLINE | ID: mdl-34383175

RÉSUMÉ

Whether cefazolin is as effective and safer than antistaphylococcal penicillins (ASPs) for the treatment of methicillin-susceptible Staphylococcus aureus (MSSA) infective endocarditis (IE) is still debated in the absence of a randomized controlled trial. In this quasi-experimental study, we aimed to assess the effectiveness and safety of these two treatments in MSSA-IE, using the ASPs nationwide shortage in April 2016 as a unique opportunity to overcome the indication bias associated with observational studies. In this single-centre study, we compared patients with Duke-Li definite MSSA-IE treated with ASPs from January 2015 to March 2016 versus those treated with cefazolin from April 2016 to December 2018, when ASPs were not available. Effectiveness outcome was 90-day all-cause mortality. Safety outcomes included significant decrease in GFR and significant increase in serum liver enzymes. Logrank test was used to compare survival rates. Of 73 patients with MSSA-IE, 35 and 38 were treated with ASPs and cefazolin, respectively. Baseline patients' characteristics (demography, native or prosthetic valve IE, clinical characteristics, cardiac and septic complications) were similar between groups. Ninety-day all-cause mortality was 28.6% and 21.1%, in patients treated with ASPs and cefazolin, respectively (logrank p = 0.5727). There was no difference between groups for incident renal or liver toxicity events: acute kidney injury 45.7% vs. 44.7% (p = 0.933), increased ALT 5.7% vs. 13.2% (p = 0.432), bilirubin increase 5.7% vs. 10.5% (p = 0.676), in ASPs vs. cefazolin groups, respectively. In this quasi-experimental, effectiveness and safety did not statistically differ between ASPs and cefazolin for MSSA-IE treatment.


Sujet(s)
Antibactériens/administration et posologie , Céfazoline/administration et posologie , Endocardite bactérienne/traitement médicamenteux , Pénicillines/administration et posologie , Infections à staphylocoques/traitement médicamenteux , Staphylococcus aureus/effets des médicaments et des substances chimiques , Adulte , Sujet âgé , Endocardite bactérienne/microbiologie , Femelle , Humains , Mâle , Méticilline/administration et posologie , Adulte d'âge moyen , Essais contrôlés non randomisés comme sujet , Infections à staphylocoques/microbiologie , Staphylococcus aureus/génétique , Staphylococcus aureus/isolement et purification
6.
Infect Dis Now ; 51(2): 140-145, 2021 03.
Article de Anglais | MEDLINE | ID: mdl-32565274

RÉSUMÉ

OBJECTIVES: Emerging infectious diseases are a public health issue of international concern. Identifying methods to limit their expansion is essential. We assessed the feasibility of a screening strategy in which each traveler would actively participate in the screening process after an intercontinental flight by reporting their own health status via a web-based self-administered questionnaire. PATIENTS AND METHODS: In 2015 and 2017, we invited passengers arriving at or departing from Pointe-à-Pitre international airport to answer an online health questionnaire during the four days following their arrival from or at Paris-Orly international airport. SPIRE 1 was intended for passengers arriving at Pointe-à-Pitre and was conceived as a pilot study. SPIRE 2 was an improved version of SPIRE 1 and consisted in three parts, which permitted to further assess the benefits of pre-flight request and email follow-up. Endpoints were the connection rates and response rates to online health questionnaire. RESULTS: For SPIRE 1, 4/1038 travelers (0.4%) completed the two steps of the online health questionnaire. In SPIRE 2, response rates ranged from 3/1059 (0.3%) to 19/819 (2.3%). Response rates were significantly better when passengers were approached before their flight. CONCLUSIONS: The yield of an online health questionnaire was unexpectedly low.


Sujet(s)
Maladies transmissibles émergentes/diagnostic , Internet , Dépistage de masse/méthodes , Autorapport , Voyage , Véhicules de transport aérien , Études de faisabilité , État de santé , Humains , Paris , Projets pilotes , Santé publique , Enquêtes et questionnaires , Médecine des voyages
9.
Clin Microbiol Infect ; 26(9): 1192-1200, 2020 Sep.
Article de Anglais | MEDLINE | ID: mdl-31927117

RÉSUMÉ

OBJECTIVES: To identify factors associated with unfavourable in-hospital outcome (death or disability) in adults with community-acquired bacterial meningitis (CABM). METHODS: In a prospective multicentre cohort study (COMBAT; February 2013 to July 2015), all consecutive cases of CABM in the 69 participating centres in France were enrolled and followed up for 12 months. Factors associated with unfavourable outcome were identified by logistic regression and long-term disability was analysed. RESULTS: Among the 533 individuals enrolled, (Streptococcus pneumoniae 53.8% (280/520 isolates identified), Neisseria meningitidis 21.3% (111/520), others 24.9% (129/520)), case fatality rate was 16.9% (90/533) and unfavourable outcome occurred in 45.0% (225/500). Factors independently associated with unfavourable outcome were: age >70 years (adjusted odds ratio (aOR) 4.64; 95% CI 1.93-11.15), male gender (aOR 2.11; 95% CI 1.25-3.57), chronic renal failure (aOR 6.65; 95% CI 1.57-28.12), purpura fulminans (aOR 4.37; 95% CI 1.38-13.81), localized neurological signs (aOR 3.72; 95% CI 2.29-6.05), disseminated intravascular coagulation (aOR 3.19; 95% CI 1.16-8.79), cerebrospinal fluid (CSF) white-cell count <1500 cells/µL (aOR 2.40; 95% CI 1.42-4.03), CSF glucose concentration (0.1-2.5 g/L: aOR 1.92; 95% CI 1.01-3.67; <0.1 g/L: aOR 2.24; 95% CI 1.01-4.97), elevated CSF protein concentration (aOR 1.09; 95% CI 1.03-1.17), time interval between hospitalization and lumbar puncture >1 day (aOR 2.94; 95% CI 1.32-6.54), and S. pneumoniae meningitis (aOR 4.99; 95% CI 1.98-12.56), or meningitis other than N. meningitidis (aOR 4.54; 95% CI 1.68-12.27). At 12 months, 26.7% (74/277) had hearing loss, 32.8% (87/265) depressive symptoms, 31.0% (86/277) persistent headache, and 53.4% had a physical health-related quality of life (142/266) <25th centile of the distribution of the score in the general French population (p < 0.0001). CONCLUSIONS: The burden of CABM (death, disability, depression, impaired quality of life and hearing loss) is high. Identification of cases from the first symptoms may improve prognosis. CLINICALTRIAL: Gov identification number: NCT01730690.


Sujet(s)
Infections communautaires/microbiologie , Infections communautaires/anatomopathologie , Méningite bactérienne/complications , Méningite bactérienne/anatomopathologie , Adulte , Sujet âgé , Antibactériens/administration et posologie , Antibactériens/usage thérapeutique , Études de cohortes , Infections communautaires/traitement médicamenteux , Infections communautaires/mortalité , Femelle , Hospitalisation , Humains , Mâle , Méningite bactérienne/traitement médicamenteux , Méningite bactérienne/mortalité , Tests de sensibilité microbienne , Adulte d'âge moyen , Études prospectives , Facteurs de risque , Résultat thérapeutique
10.
J Hosp Infect ; 104(2): 214-235, 2020 Feb.
Article de Anglais | MEDLINE | ID: mdl-31715282

RÉSUMÉ

Mycobacterial infection-related morbidity and mortality in patients following cardiopulmonary bypass surgery is high and there is a growing need for a consensus-based expert opinion to provide international guidance for diagnosing, preventing and treating in these patients. In this document the International Society for Cardiovascular Infectious Diseases (ISCVID) covers aspects of prevention (field of hospital epidemiology), clinical management (infectious disease specialists, cardiac surgeons, ophthalmologists, others), laboratory diagnostics (microbiologists, molecular diagnostics), device management (perfusionists, cardiac surgeons) and public health aspects.


Sujet(s)
Infection croisée , Infections à mycobactéries non tuberculeuses , Mycobacterium , Antibactériens/usage thérapeutique , Procédures de chirurgie cardiaque/effets indésirables , Procédures de chirurgie cardiaque/méthodes , Cardiologie , Pontage cardiopulmonaire , Maladies transmissibles , Infection croisée/diagnostic , Infection croisée/traitement médicamenteux , Infection croisée/microbiologie , Infection croisée/prévention et contrôle , Contamination de matériel , Humains , Mycobacterium/isolement et purification , Infections à mycobactéries non tuberculeuses/diagnostic , Infections à mycobactéries non tuberculeuses/traitement médicamenteux , Infections à mycobactéries non tuberculeuses/prévention et contrôle , Facteurs de risque , Sociétés médicales , Royaume-Uni
11.
Rev Epidemiol Sante Publique ; 68(2): 133-136, 2020 Apr.
Article de Anglais | MEDLINE | ID: mdl-31862272

RÉSUMÉ

The social, economic and political consequences of emerging infectious disease (EID) may escape the sphere in which they first arise. In recent years, many EIDs have revealed the close links between human, animal and plant health, highlighting the need for multi-scale, multisectorial EID management. Human beings play a dual role in EID because they can promote their development through numerous human-environment interfaces and expanding international trade. On the other hand, their ability to analyze, interpret and act on the determinants of EID allows them to access the expertise necessary to control these EIDs. This expertise must be constantly adapted to remain relevant as the EID evolves, particularly in its virulence or transmission channels. Flexibility should become an inherent part of the expertise-based decision-making process even if it means going backwards. A certain degree of transparency and feedback to citizens is necessary for the acceptability of political decisions basing on expertise. A key step in the management of EID is the appropriate management of the early signal of infectious emergence. This step combines multidisciplinary skills allowing access to the best pathway for containing EID by implementing early countermeasures adapted to the situation. New digital technologies could significantly improve this early detection phase. Finally, experts have a fundamental role to play because they are located at the interface between operational actors and decision-makers, which allows multidirectional feedback, ideally in real time, between professional actors and decision makers. To combat current and future EIDs, expertise should be based on a multi-sectorial approach, promotion of collegiality and continuously adaptation to the evolving nature of EIDs.


Sujet(s)
Maladies transmissibles émergentes/prévention et contrôle , Maladies transmissibles émergentes/thérapie , Prévention des infections , Recherche interdisciplinaire , Médecine préventive , Animaux , Maladies transmissibles émergentes/épidémiologie , Expertise , Humains , Prévention des infections/méthodes , Prévention des infections/organisation et administration , Prévention des infections/tendances , Communication interdisciplinaire , Recherche interdisciplinaire/méthodes , Recherche interdisciplinaire/organisation et administration , Recherche interdisciplinaire/tendances , Médecine préventive/méthodes , Médecine préventive/organisation et administration , Médecine préventive/tendances , Recherche/organisation et administration , Recherche/normes , Recherche/tendances
14.
BMC Infect Dis ; 19(1): 570, 2019 Jul 01.
Article de Anglais | MEDLINE | ID: mdl-31262263

RÉSUMÉ

BACKGROUND: Kodamaea ohmeri is a yeast is frequently mistaken for Candida, which belongs to the same family. This micro-organism has been reported to cause life-threatening infections in humans. CASE PRESENTATION: A 81-year-old woman developed a severe fungemic pulmonary infection due to Kodamaea ohmeri that was identified from bronchoalveolar fluid and blood cultures, which is unusual in immunocompetent patients. Because K. ohmeri was first wrongly identified as Candida albicans, the patient inadequately received caspofungin, which was clinically ineffective, especially as the strain was resistant to echinocandins. Clinical cure was obtained after treatment was switched to voriconazole. CONCLUSIONS: An increasing number of serious infections due to K. ohmeri has been reported in the literature, but the correct identification of this micro-organism remains difficult.


Sujet(s)
Fongémie/traitement médicamenteux , Fongémie/microbiologie , Saccharomycetales/pathogénicité , Sujet âgé de 80 ans ou plus , Antifongiques/usage thérapeutique , Candida albicans/pathogénicité , Erreurs de diagnostic , Résistance des champignons aux médicaments/effets des médicaments et des substances chimiques , Échinocandines/usage thérapeutique , Femelle , Humains , Tests de sensibilité microbienne , Saccharomycetales/effets des médicaments et des substances chimiques , Voriconazole/usage thérapeutique
15.
Clin Microbiol Infect ; 25(10): 1246-1252, 2019 Oct.
Article de Anglais | MEDLINE | ID: mdl-31055167

RÉSUMÉ

OBJECTIVES: The aim was to describe the impact of infective endocarditis (IE) on functional, cognitive and nutritional statuses, and to estimate the influence of these parameters on surgical management and mortality. METHOD: This was a prospective study over 13 months in 14 French hospitals, including patients ≥75 years of age with definite or possible IE. A comprehensive geriatric assessment (CGA) was performed during the first week of hospitalization, including a retrospective estimation of functional status 2 months before hospitalization, and 3 months after. RESULTS: A total of 120 patients were included (mean age 83.1 ± 5.0 (75-101) years). IE was associated with a dramatic impairment of functional status between 2 months prior hospitalization and the first geriatric evaluation (90.8% able to walk vs. 35.5% (p < 0.0001), ADL (Activities in Daily Living) 5.0 ± 1.7 vs. 3.1 ± 2.1 (p < 0.0001)). The 19 operated patients (15.8%) had less comorbidities (cumulative illness rating scale geriatric 10.8 ± 8.2 vs. 15.3 ± 7.1 (p 0.0176)), better functional (ADL 5.9 ± 0.4 vs. 4.9 ± 1.8 (p 0.0171) and nutritional (mini nutritional assessment 20.4 ± 5.0 vs. 17.3 ± 6.2 (p 0.0501)) statuses than non-operated patients. Among all infectious, cardiac and geriatric parameters, body mass index (HR 0.9, range 0.8-1, p 0.05) and ADL at the time of the first evaluation (HR 0.7, range 0.6-0.9, p 0.002) were the sole independent predictors of the 3-month (32.5%) and 1-year mortality (42.5%). Three months later, the 57 assessed patients only partially recovered their ADL (3.7 ± 1.9 vs. 5.3 ± 1.4 2 months prior hospitalization and 4.6 ± 1.9 at the first CGA; p < 0.0001). CONCLUSION: Functional and nutritional abilities are crucial components that can be accurately explored through a CGA when managing IE in oldest patients.


Sujet(s)
Endocardite/mortalité , Endocardite/anatomopathologie , Évaluation gériatrique , Sujet âgé , Sujet âgé de 80 ans ou plus , Comorbidité , Endocardite/chirurgie , Femelle , France , Hospitalisation/statistiques et données numériques , Humains , Mâle , État nutritionnel , Études prospectives , Analyse de survie
16.
Med Mal Infect ; 48(2): 95-102, 2018 Mar.
Article de Anglais | MEDLINE | ID: mdl-29169817

RÉSUMÉ

CONTEXT: In 2012, the French Infectious Diseases Society (French acronym SPILF) initiated the "Coordination of epidemic and biological risk" (SPILF-COREB - Emergences [SCE]) group to support the readiness and response of healthcare workers (HCWs) to new alerts. OBJECTIVE: To present the SCE group, its functioning, and the main support it provided for frontline HCWs. METHODS: A multidisciplinary group of heads of infectious disease departments from reference hospitals was created to build a network of clinical expertise for care, training, and research in the field of epidemic and biological risk (EBR). The network developed a set of standardized operational procedures (SOPs) to guide interventions to manage EBR-suspect patients. RESULTS: A working group created the SOP aimed at frontline HCWs taking care of patients. Priority was given to the development of a generic procedure, which was then adapted according to the current alert. Five key steps were identified and hierarchized: detecting, protecting, caring for, alerting, and referring the EBR patient. The interaction between clinicians and those responsible for the protection of the community was crucial. The SOPs validated by the SPILF and its affiliates were disseminated to a wide range of key stakeholders through various media including workshops and the SPILF's website. CONCLUSION: SPILF can easily adapt and timely mobilize the EBR expertise in case of an alert. The present work suggests that sharing and discussing this experience, initiated at the European level, can generate a new collective expertise and needs to be further developed and strengthened.


Sujet(s)
Infections à coronavirus/épidémiologie , Infections à coronavirus/prévention et contrôle , Épidémies/prévention et contrôle , Fièvre hémorragique à virus Ebola/épidémiologie , Fièvre hémorragique à virus Ebola/prévention et contrôle , Coronavirus du syndrome respiratoire du Moyen-Orient , France/épidémiologie , Humains , Risque , Facteurs de risque , Sociétés médicales
17.
BMC Infect Dis ; 17(1): 106, 2017 01 31.
Article de Anglais | MEDLINE | ID: mdl-28143423

RÉSUMÉ

BACKGROUND: Neurocysticercosis is endemic in most countries of Central and South America but has rarely been described in the French West Indies. We aimed to better understand the clinical and radiological presentation of our cases. CASE PRESENTATION: We report three cases of neurocysticercosis in patients living in Guadeloupe, with different clinical and radiological presentations. CONCLUSION: Given the eventuality of autochtonous transmission, the diagnosis should be considered in all patients living in Guadeloupe presenting with seizures.


Sujet(s)
Neurocysticercose/diagnostic , Adulte , Diagnostic différentiel , Femelle , Guadeloupe , Humains , Imagerie par résonance magnétique , Mâle , Adulte d'âge moyen , Neurocysticercose/complications , Neurocysticercose/imagerie diagnostique , Neurocysticercose/microbiologie , Crises épileptiques/étiologie , Voyage , Jeune adulte
18.
Epidemiol Infect ; 144(11): 2363-70, 2016 08.
Article de Anglais | MEDLINE | ID: mdl-27033595

RÉSUMÉ

To describe the consequences of medical care interruptions (MCIs) we selected patients with at least two medical encounters between January 2006 and June 2013 in the Dat'AIDS cohort. Patients with any time interval >15 months between two visits were defined as having a MCI, as opposed to uninterrupted follow-up (UFU). Patients' characteristics at the time of HIV diagnosis and at the censoring date were compared between groups. Cox proportional hazards models were built to assess the role of interruptions on survival (total and AIDS-free). Of 11 116 patients, 824 had at least one MCI. These patients were younger at the time of HIV diagnosis (30 vs. 33 years, P < 0·0001). MCI was less frequent in men having sex with men vs. heterosexual patients [odds ratio (OR) 0·81, 95% confidence interval (CI) 0·69-0·96)], and a centre effect was described. MCI was independently associated with AIDS (OR 2·54, 95% CI 2·10-3·09) and death (OR 2·65, 95% CI 1·94-3·61). At the censoring date, 52·2% of patients with at least one MCI had viral load below detection vs. 85·3% of the UFU group (P < 0·0001). In conclusion, MCIs were associated with patients' survival and with the proportion of viral loads below detection in our cohort, compromising individual and collective treatment benefits.


Sujet(s)
Infections à VIH/prévention et contrôle , Observance par le patient/statistiques et données numériques , Adulte , Études de cohortes , Femelle , France , Humains , Mâle , Adulte d'âge moyen , Odds ratio , Modèles des risques proportionnels , Facteurs de risque , Charge virale , Jeune adulte
19.
Clin Microbiol Infect ; 22(2): 163-170, 2016 Feb.
Article de Anglais | MEDLINE | ID: mdl-26493845

RÉSUMÉ

International guidelines are available to help physicians prescribe appropriate antibiotic regimens to patients with infective endocarditis (IE). However some topics of these guidelines are controversial. We conducted an international survey to assess physicians' adherence to these guidelines, focusing on these controversial items. An invitation to participate to a 15-question online survey was sent in 2012-2013 to European Society of Clinical Microbiology and Infectious Diseases (ESCMID) members, scientific societies and corresponding authors of publications on IE mentioned in PubMed from 1990 to 2012, inclusive. Eight hundred thirty-seven physicians participated in the survey, and 625 (74.7%) completed it over the first question. The results showed great heterogeneity of practices. Claiming to follow guidelines was marginally associated with more guideline-based strategies. Gentamicin use depended on causative pathogens (p <0.001) and physician specialty (p 0.02). Eighty-six per cent of the physicians favoured vancomycin alone or in combination with gentamicin or rifampicin as a first-line treatment for left-sided native valve methicillin-resistant Staphylococcus aureus IE, 31% considered switching to oral therapy as a therapeutic option and 33% used the ampicillin and ceftriaxone combination for enterococcal IE as a first-line therapy. Physician specialty significantly affected the choice of a therapeutic strategy, while practicing in a university hospital or the number of years of practice had virtually no impact. Our survey, the largest on IE treatment, underscores important heterogeneity in practices for treatment of IE. Nonetheless, physicians who do not follow guidelines can have rational strategies that are based on the literature. These results could inform the revision of future guidelines and identify unmet needs for future studies.


Sujet(s)
Endocardite bactérienne/traitement médicamenteux , Adhésion aux directives , Guides de bonnes pratiques cliniques comme sujet , Antibactériens/usage thérapeutique , Études transversales , Prise en charge de la maladie , Humains , Médecins , Enquêtes et questionnaires
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...